(1)
Molecular Docking Study of Nigella Sativa Alkaloid Compounds As the Inhibitor of Papain-Like Protease SARS-CoV-2. J. Trop. Pharm. Chem 2025, 7 (1), 33-40. https://doi.org/10.30872/j.trop.pharm.chem.v7i1.148.